STRYKER CORP (SYK) Gross Margin
- Gross margin · 12 months: Value 64.98%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 64.98% | Gross profit / revenue. Period ending 2026-06-30. $16.79B ÷ $25.84B × 100 ≈ 64.98% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 16.79B USD | Gross Profit |
| Revenue | 25.84B USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $16.79B | $25.84B | (m) | 64.98% |
| 2026-03-31 | $16.13B | $25.27B | (m) | 63.83% |
| 2025-12-31 | $16.07B | $25.12B | (m) | 63.96% |
| 2025-09-30 | $15.61B | $24.38B | (m) | 64.03% |
| 2025-06-30 | $15.28B | $23.82B | (m) | 64.14% |
| 2025-03-31 | $14.85B | $23.22B | (m) | 63.96% |
| 2024-12-31 | $14.44B | $22.59B | (m) | 63.91% |
| 2024-09-30 | $13.97B | $21.97B | (m) | 63.57% |
| 2024-06-30 | $13.61B | $21.39B | (m) | 63.63% |
| 2024-03-31 | $13.38B | $20.96B | (m) | 63.80% |
| 2023-12-31 | $13.06B | $20.50B | (m) | 63.70% |
| 2023-09-30 | $12.59B | $19.89B | (m) | 63.32% |
| 2023-06-30 | $12.21B | $19.45B | (m) | 62.79% |
| 2023-03-31 | $11.86B | $18.95B | (m) | 62.58% |
| 2022-12-31 | $11.58B | $18.45B | (m) | 62.76% |
| 2022-09-30 | $11.39B | $17.95B | (m) | 63.44% |
| 2022-06-30 | $11.25B | $17.63B | (m) | 63.80% |
| 2022-03-31 | $11.19B | $17.43B | (m) | 64.22% |
| 2021-12-31 | $10.97B | $17.11B | (m) | 64.11% |
| 2021-09-30 | $10.64B | $16.67B | (m) | 63.83% |
| 2021-06-30 | $10.46B | $16.25B | (m) | 64.38% |
| 2021-03-31 | $9.23B | $14.72B | (m) | 62.75% |
| 2020-12-31 | $9.06B | $14.35B | (m) | 63.11% |
| 2020-09-30 | $9.04B | $14.22B | (m) | 63.59% |
| 2020-06-30 | $8.91B | $14.07B | (m) | 63.34% |
| 2020-03-31 | $9.74B | $14.96B | (m) | 65.15% |
| 2019-12-31 | $9.70B | $14.88B | (m) | 65.14% |
| 2019-09-30 | $9.45B | $14.55B | (m) | 64.95% |
| 2019-06-30 | $9.27B | $14.20B | (m) | 65.29% |
| 2019-03-31 | $9.08B | $13.88B | (m) | 65.47% |
| 2018-12-31 | $8.94B | $13.60B | (m) | 65.72% |
| 2018-09-30 | $8.72B | $13.28B | (m) | 65.65% |
| 2018-06-30 | $8.54B | $13.04B | (m) | 65.53% |
| 2018-03-31 | $8.35B | $12.73B | (m) | 65.56% |
| 2017-12-31 | $8.17B | $12.44B | (m) | 65.68% |
| 2017-09-30 | $8.02B | $12.13B | (m) | 66.12% |
| 2017-06-30 | $7.91B | $11.96B | (m) | 66.16% |
| 2017-03-31 | $7.76B | $11.79B | (m) | 65.87% |
| 2016-12-31 | $7.50B | $11.32B | (m) | 66.18% |
| 2016-09-30 | $7.23B | $10.88B | (m) | 66.42% |
| 2016-06-30 | $6.98B | $10.47B | (m) | 66.67% |
| 2016-03-31 | $6.74B | $10.06B | (m) | 67.01% |
| 2015-12-31 | $6.60B | $9.95B | (m) | 66.38% |
| 2015-09-30 | $6.53B | $9.85B | (m) | 66.29% |
| 2015-06-30 | $6.46B | $9.82B | (m) | 65.85% |
| 2015-03-31 | $6.41B | $9.75B | (m) | 65.73% |
| 2014-12-31 | $6.38B | $9.68B | (m) | 65.98% |
| 2014-09-30 | $6.27B | $9.53B | (m) | 65.87% |
| 2014-06-30 | $6.18B | $9.29B | (m) | 66.50% |
| 2014-03-31 | $6.10B | $9.14B | (m) | 66.80% |
| 2013-12-31 | $6.04B | $9.02B | (m) | 67.00% |
| 2013-09-30 | $6.02B | $8.89B | (m) | 67.72% |
| 2013-06-30 | $5.95B | $8.79B | (m) | 67.66% |
| 2013-03-31 | $5.90B | $8.69B | (m) | 67.94% |
| 2012-12-31 | $5.88B | $8.66B | (m) | 67.88% |
| 2012-09-30 | $5.76B | $8.53B | (m) | 67.47% |
| 2012-06-30 | $5.72B | $8.51B | (m) | 67.23% |
| 2012-03-31 | $5.62B | $8.45B | (m) | 66.51% |
| 2011-12-31 | $5.50B | $8.31B | (m) | 66.16% |
| 2011-09-30 | $5.39B | $8.09B | (m) | 66.68% |
| 2011-06-30 | $5.26B | $7.82B | (m) | 67.19% |
| 2011-03-31 | $5.14B | $7.54B | (m) | 68.24% |
| 2010-12-31 | $5.03B | $7.32B | (m) | 68.77% |
| 2010-09-30 | $4.90B | $7.16B | (m) | 68.51% |
| 2010-06-30 | $4.79B | $7.04B | (m) | 68.02% |
| 2010-03-31 | $4.67B | $6.92B | (m) | 67.50% |
| 2009-12-31 | $4.54B | $6.72B | (m) | 67.52% |
| 2009-09-30 | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) |
| 2008-12-31 | $4.59B | $6.72B | (m) | 68.27% |
| 2008-09-30 | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) |
| 2007-12-31 | $4.14B | $6.00B | (m) | 68.92% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |